Recent News

• 09.08.2025 - H.C. Wainwright 27th Annual Global Investment Conference
• 09.05.2025 - Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
• 09.02.2025 - Citi’s 2025 BioPharma Back to School Conference
• 08.26.2025 - Syndax Announces Participation in September Investor Conferences
• 08.26.2025 - Syndax Announces Participation in September Investor Conferences
• 08.06.2025 - Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
• 08.04.2025 - Syndax Second Quarter 2025 Conference Call
• 08.04.2025 - Syndax Reports Second Quarter 2025 Financial Results and Provides Business Update
• 08.04.2025 - Syndax Reports Second Quarter 2025 Financial Results and Provides Business Update
• 07.28.2025 - Syndax to Announce Second Quarter 2025 Financial Results and Host Conference Call and Webcast on August 4, 2025

Recent Filings

• 08.18.2025 - 144 Report of proposed sale of securities
• 08.18.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 08.18.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.14.2025 - 144 Report of proposed sale of securities
• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.13.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.04.2025 - EX-99.1 EX-99.1
• 08.04.2025 - 8-K Current report
• 08.04.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]